Auspherix Expands SAB
Anti-infectives company Auspherix Ltd. has appointed Professor William Hope to its scientific advisory board (SAB). Hope is an NIHR clinical scientist and professor of therapeutics and infectious diseases at the University of Liverpool, UK and was recently named chair in the department of molecular and clinical pharmacology at the university. Previously, he was chair in therapeutics and infectious diseases at the University of Manchester.
You may also be interested in...
US FDA will hold 10 December advisory committee on Pfizer/BioNTech's just-filed application; the WHO issued a recommendation against Gilead's Veklury for hospitalized patients.
Board directors appointed at Athersys, Trillium Therapeutics and Viatris
Coronavirus Update: CureVac's EU Vaccine Deal, J&J's New Vaccine Study, BioNTech/Fosun Get China Go-Ahead
CureVac seals EU Deal for 405 million doses of CVnCoV, a second Phase III trial for J&J’s COVID-19 vaccine starts, and BioNTech, Fosun get OK for China vaccine trial.